Angesichts der sich abzeichnenden Fristen, die von den Behörden gesetzt werden, müssen alle Pharmaunternehmen den Nitrosamingehalt in ihren Arzneimitteln bewerten und kontrollieren. Die Lösungen sind oft mehrschichtig und können einfache und sichere Nitritfänger in der endgültigen Arzneimittelformulierung enthalten. In diesem AAPS e-chalk talk erörtern Experten von dsm-firmenich wichtige Überlegungen zur Nitrosaminminderung in Arzneimitteln unter Verwendung von Nitritfängern.
Lernziele:
Diese Sitzung dauert 30 Minuten.
Ascorbic acid, and other nitrite scavengers, have been shown to act as functional excipients in drug products that can reduce nitrosamine formation by blocking nitrosation reactions.
Discover the latest insights on nitrosamine risk mitigation presented by dsm-firmenich during an eChalk Talk hosted by the American Association of Pharmaceutical Scientists (AAPS).
Discover how dsm-firmenich is turning insights into innovation this World Patient Safety Day, from nitrosamine risk mitigation to cannabinoid-based therapeutics.
Have an idea for a new project, a groundbreaking innovation, or a need for expert services? Let’s talk.
Don’t just take our word for it. Discover how our solutions can support your product development journey.
Customized blends of functional ingredients in one single, efficient premix.
Streamline your product development process and get to market faster.
From trade shows to conferences and other industry events, find out where you can meet us next.
Talking Nutrition, Health & Care
Explore new science, consumer insights, industry news and more in our latest articles.
Discover educational whitepapers, webinars, publications and technical information.
Request samples, place orders and view product documentation.